Sapience Therapeutics is focused on discovering and developing peptide-based therapeutics to previously ‘undruggable’ targets for major unmet medical needs, particularly high mortality cancers.
Our drug candidates target protein-protein interactions (“PPIs”) that are responsible for either making the cells cancerous or dampening the immune response against tumors. These targets are considered ‘undruggable’ becaus...
Sapience Therapeutics is focused on discovering and developing peptide-based therapeutics to previously ‘undruggable’ targets for major unmet medical needs, particularly high mortality cancers.
Our drug candidates target protein-protein interactions (“PPIs”) that are responsible for either making the cells cancerous or dampening the immune response against tumors. These targets are considered ‘undruggable’ because they are PPIs that reside inside of the cell, making them difficult to treat with small molecule drugs such as chemotherapies (which are incapable of disrupting PPIs) or newer biologic-based drugs.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.